<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To document the radiologic abnormalities seen in the central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) during and after treatment of childhood <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images (19 patients) and CT scans (12 patients) were reviewed retrospectively in 19 children and adolescents with neurologic complications of <z:hpo ids='HP_0001909'>leukemia</z:hpo> or its treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were divided into two groups: the first included those with disease-related complications of <z:hpo ids='HP_0001909'>leukemia</z:hpo>, such as meningeal and parenchymal <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:e sem="disease" ids="C0152276" disease_type="Neoplastic Process" abbrv="">chloroma</z:e>, and cerebrovascular disorders; the second included patients with treatment-related neurotoxicity and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> caused by immunocompromised states </plain></SENT>
<SENT sid="3" pm="."><plain>Pathologic confirmation of the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> lesions was obtained in eight patients </plain></SENT>
<SENT sid="4" pm="."><plain>Factors that predisposed to the development of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-related or treatment-related complications were determined by reviewing the medical records </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Among the 19 patients, 10 had two or more different <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> abnormalities found on CT scans or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images </plain></SENT>
<SENT sid="6" pm="."><plain>The imaging abnormalities seen in 12 patients during treatment included sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (n = 3), transient gray or white matter <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (n = 2), presumed disseminated microinfarcts (n = 1), <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> or <z:mpath ids='MPATH_124'>infarct</z:mpath> (n = 3), inflammatory demyelinating <z:e sem="disease" ids="C0032587" disease_type="Disease or Syndrome" abbrv="">polyradiculoneuropathy</z:e> (n = 1), <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> (n = 4, 2 <z:mp ids='MP_0001794'>bacterial</z:mp> and 2 fungal), and meningeal <z:hpo ids='HP_0001909'>leukemia</z:hpo> (n = 2) </plain></SENT>
<SENT sid="7" pm="."><plain>After therapy, seven patients had <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> imaging abnormalities, including secondary <z:mp ids='MP_0009277'>brain tumors</z:mp> (2 malignant <z:hpo ids='HP_0009733'>gliomas</z:hpo> and 1 CNS <z:hpo ids='HP_0002665'>lymphoma</z:hpo>), spinal <z:e sem="disease" ids="C0152276" disease_type="Neoplastic Process" abbrv="">chloroma</z:e> (n = 1), necrotizing <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo> and mineralizing <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> (n = 3), cerebral <z:e sem="disease" ids="C0026718" disease_type="Disease or Syndrome" abbrv="">mucormycosis</z:e> (n = 1), spontaneous <z:hpo ids='HP_0002170'>intracranial hemorrhage</z:hpo> (n = 3), and spinal meningeal <z:hpo ids='HP_0001909'>leukemia</z:hpo> (n = 1) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The wide spectrum of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> abnormalities that occur during and after treatment for <z:hpo ids='HP_0001909'>leukemia</z:hpo> is related to the inherent risk of the <z:hpo ids='HP_0001909'>leukemia</z:hpo> itself, to the treatment method, and to the duration of survival </plain></SENT>
<SENT sid="9" pm="."><plain>Because many neurologic complications of <z:hpo ids='HP_0001909'>leukemia</z:hpo> are treatable, early diagnosis is essential </plain></SENT>
</text></document>